메뉴 건너뛰기




Volumn 20, Issue 5, 2004, Pages 516-518

Tyrian purple indirubins: A source of GSK-3 inhibitors;La pourpre de Méditerranée, une source inattendue d'inhibiteurs de GSK-3

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEUKEMIC AGENT; CYCLIN A; CYCLIN DEPENDENT KINASE; ENZYME INHIBITOR; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; INDIRUBIN; TYRIAN PURPLE INDIRUBIN; UNCLASSIFIED DRUG;

EID: 2442438812     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2004205516     Document Type: Note
Times cited : (4)

References (14)
  • 1
    • 0042894451 scopus 로고    scopus 로고
    • Tyrian purple: 6,6′-dibromoindigo and related compounds
    • Cooksey CJ. Tyrian purple: 6,6′-dibromoindigo and related compounds. Molecules 2001; 6: 736-69.
    • (2001) Molecules , vol.6 , pp. 736-769
    • Cooksey, C.J.1
  • 4
    • 0033128165 scopus 로고    scopus 로고
    • Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases
    • Hoessel R, Leclerc S, Endicott J, et al. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat Cell Biol 1999; 1: 60-7.
    • (1999) Nat Cell Biol , vol.1 , pp. 60-67
    • Hoessel, R.1    Leclerc, S.2    Endicott, J.3
  • 5
    • 0035963318 scopus 로고    scopus 로고
    • Anti-mitotic properties of indirubin-3′-monoxime, a CDK/GSK-3 inhibitor: Induction of endoreplication following prophase arrest
    • Damiens E, Baratte B, Marie D, et al. Anti-mitotic properties of indirubin-3′-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest. Oncogene 2001; 20: 3786-97.
    • (2001) Oncogene , vol.20 , pp. 3786-3797
    • Damiens, E.1    Baratte, B.2    Marie, D.3
  • 6
    • 0034988970 scopus 로고    scopus 로고
    • Inhibitor binding to active and inactive CDK2. The crystal structure of a CDK2-cyclin A/indirubin-5-sulphonate
    • Davies TG, Tunnah P, Meijer L, et al. Inhibitor binding to active and inactive CDK2. The crystal structure of a CDK2-cyclin A/indirubin-5-sulphonate. Structure 2001; 9: 389-97.
    • (2001) Structure , vol.9 , pp. 389-397
    • Davies, T.G.1    Tunnah, P.2    Meijer, L.3
  • 7
    • 0242710962 scopus 로고    scopus 로고
    • Structures of P. falciparum PfPK5 test the CDK regulation paradigm and suggest mechanisms of small molecule inhibition
    • Holton S, Merckx A, Burgess D, et al. Structures of P. falciparum PfPK5 test the CDK regulation paradigm and suggest mechanisms of small molecule inhibition. Structure 2003; 11: 1329-37.
    • (2003) Structure , vol.11 , pp. 1329-1337
    • Holton, S.1    Merckx, A.2    Burgess, D.3
  • 8
    • 0035808457 scopus 로고    scopus 로고
    • Indirubins inhibit glycogen synthase kinase-3β and CDK5/p25, two kinases involved in abnormal tau phosphorylation in Alzheimer's disease - A property common to most CDK inhibitors?
    • Leclerc S, Garnier M, Hoessel R, et al. Indirubins inhibit glycogen synthase kinase-3β and CDK5/p25, two kinases involved in abnormal tau phosphorylation in Alzheimer's disease - a property common to most CDK inhibitors? J Biol Chem 2001; 276: 251-60.
    • (2001) J Biol Chem , vol.276 , pp. 251-260
    • Leclerc, S.1    Garnier, M.2    Hoessel, R.3
  • 9
    • 0346875916 scopus 로고    scopus 로고
    • GSK-3 selective inhibitors derived from Tyrian purple indirubins
    • Meijer L, Skaltsounis AL, Magiatis P, et al. GSK-3 selective inhibitors derived from Tyrian purple indirubins. Chem Biol 2003; 10: 1255-66.
    • (2003) Chem Biol , vol.10 , pp. 1255-1266
    • Meijer, L.1    Skaltsounis, A.L.2    Magiatis, P.3
  • 10
    • 2442589341 scopus 로고    scopus 로고
    • Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases
    • Polychronopoulos P, Magiatis P, Skaltsounis L, et al. Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases. J Med Chem 2004; 47: 935-46.
    • (2004) J Med Chem , vol.47 , pp. 935-946
    • Polychronopoulos, P.1    Magiatis, P.2    Skaltsounis, L.3
  • 11
    • 0346338117 scopus 로고    scopus 로고
    • CDK versus GSK-3 inhibition: A purple haze no longer?
    • Fischer PM. CDK versus GSK-3 inhibition: a purple haze no longer? Chem Biol 2003; 10: 1144-6.
    • (2003) Chem Biol , vol.10 , pp. 1144-1146
    • Fischer, P.M.1
  • 12
    • 1242267927 scopus 로고    scopus 로고
    • Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3 specific inhibitor
    • Sato N, Meijer L, Skaltsounis L, et al. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3 specific inhibitor. Nat Med 2004; 10: 55-63.
    • (2004) Nat Med , vol.10 , pp. 55-63
    • Sato, N.1    Meijer, L.2    Skaltsounis, L.3
  • 13
    • 2442575199 scopus 로고
    • Balard, so vie, son œuvre à Montpellier de 1802 à 1840
    • Dolique R. Balard, so vie, son œuvre à Montpellier de 1802 à 1840. Rev Hist Pharm 1977; 232: 13-27.
    • (1977) Rev Hist Pharm , vol.232 , pp. 13-27
    • Dolique, R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.